drugset
Drugs / Calcium Aluminosilicate Anti-Diarrheal
last change Sep 2012 re-read 3 minutes ago

Calcium Aluminosilicate Anti-Diarrheal

also known as CASAD
Developed for
Clostridium difficile colitis
Investigated by
Salient Pharmaceuticals Incorporated · Scott and White Hospital & Clinic · Texas A&M University

Trials 1

today NCT01570634 · Ph 2
2012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01570634 Mar → Sep 2012 Clostridium difficile colitis Salient Pharmaceuticals Incorporated Terminated No outcome recorded Stop: Enrollment

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Calcium Aluminosilicate Anti-Diarrheal ClinicalTrials.gov intervention name — accepted as the source's own label NCT01570634 ↗
Known as CASAD “Calcium Aluminosilicate Anti-Diarrheal (CASAD)” NCT01570634 ↗
Route Oral “CASAD 1.5 grams po tid” NCT01570634 ↗